NCT01257308Unknown不适用
Research of the EML4-ALK Gene Expression in the Pleural Effusion or Tumor Tissue From Lung Cancer Patients
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 100
- 试验地点
- 1
研究概览
简要总结
We wants to analyse the EML4-ALK mutation rate in the patients who have non-small cell lung cancer.
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 20 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •20 or more than 20 years of age
- •The pathological diagnosis confirmed lung cancer
- •Patients have achieved pleural effusion, or surgical biopsy to obtain tumor tissue specimens
- •The patient had signed inform consent
排除标准
- •pleural effusion or tumor tissue can not be obtained
- •the patient is not suitable to join the research according to the judgement by the investigator
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
Detection of Either the EML4-ALK Gene Rearrangements or the T790M EGFR Mutation in the Plasma of Advanced NSCLC PatientsCarcinoma, Non-Small-Cell LungNCT03236675Exosome Diagnostics, Inc.60
招募中
不适用
A Retrospective Study: Evaluation of the Efficacy of Immunotherapy With Rare Mutations in Non-small Cell Lung CancerNon Small Cell Lung CancerNCT04777175Yongchang Zhang186
已完成
不适用
Monitoring study of genomic mutations in patients with EGFR mutation or ALK translocation using plasma DNAnon-small-cell lung cancerJPRN-UMIN000035628Wakayama Medical University100
已完成
2 期
Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before SurgeryLung CancerNCT00057798Roswell Park Cancer Institute21
Unknown
不适用
Acquired Resistant Mechanism of the First-generation EGFR TKIsAquired ResistanceEGFR TKIsNon-small Cell Lung CancerNCT02804217Zhejiang Cancer Hospital60